Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women
- PMID: 34177961
- PMCID: PMC8221111
- DOI: 10.3389/fimmu.2021.695201
Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women
Abstract
Background: The presence of semen in the vagina from unprotected sex may influence the immune and microbial environment of the female genital tract. Inflammatory cytokine concentrations and BV-associated bacteria in female genital secretions may influence HIV risk, although the effect of recent sexual intercourse on incident BV and the cytokine milieu of cervicovaginal secretions has rarely been measured in previous studies. Here, we investigated the extent to which partner semen impacts the cytokine response and incident BV.
Methods: At baseline, we assessed the recency of semen exposure in menstrual cup supernatants by quantifying prostate specific antigen (PSA) levels using ELISA in 248 HIV-uninfected women at high risk for HIV infection. Luminex was used to measure 48 cytokines in menstrual cup supernatants and vaginal swabs to diagnose BV by Nugent score. Point-of-care screening for Chlamydia trachomatis and Neisseria gonorrhoeae was conducted using GeneXpert while OSOM was used for Trichomonas vaginalis detection. Multivariable models, adjusted for age, sexually transmitted infections, BV, current contraception use and condom use, were used to assess the impact of semen exposure on biomarkers of inflammation and BV.
Results: Presence of PSA, indicating recent semen exposure within 48 hours prior to sampling, was observed in menstrual cup supernatants of 17% (43/248) of women. Of these women, 70% (30/43) had self-reported condom use at their last sex act and 84% (36/43) had BV (Nugent score >7). PSA presence was significantly associated with prevalent BV (Relative Risk (RR), 2.609; 95% Confidence Interval (CI), 1.104 - 6.165; p = 0.029). Furthermore, women with detectable PSA had high median concentrations of macrophage inflammatory protein- beta (MIP-1α, p=0.047) and low median concentration of the stem cell growth factor beta (SCGF-β, p=0.038) compared to those without PSA.
Conclusion: A degree of discordance between self-reports of consistent condom use and PSA positivity was observed. There was also evidence of a relationship between recent semen exposure, BV prevalence and altered cytokine concentrations. These findings suggest that PSA, as a semen biomarker, should be taken into consideration when investigating biological markers in the female genital tract and self-reported condom use in studies on reproductive and sexual health.
Keywords: bacterial vaginosis; cytokines; genital inflammation; prostate specific antigen; semen exposure.
Copyright © 2021 Mngomezulu, Mzobe, Mtshali, Osman, Liebenberg, Garrett, Singh, Rompalo, Mindel, Karim, Karim, Baxter and Ngcapu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Recent Biomarker-Confirmed Unprotected Vaginal Sex, But Not Self-reported Unprotected Sex, Is Associated With Recurrent Bacterial Vaginosis.Sex Transm Dis. 2016 Mar;43(3):172-6. doi: 10.1097/OLQ.0000000000000414. Sex Transm Dis. 2016. PMID: 26859804 Free PMC article.
-
Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study.Sex Transm Infect. 2019 Feb;95(1):5-12. doi: 10.1136/sextrans-2017-053506. Epub 2018 Jul 17. Sex Transm Infect. 2019. PMID: 30018088
-
Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women.Sex Transm Infect. 2021 Dec;97(8):555-565. doi: 10.1136/sextrans-2020-054740. Epub 2021 Feb 19. Sex Transm Infect. 2021. PMID: 33608480
-
The use of PSA as a biomarker of recent semen exposure in female reproductive health studies.J Reprod Immunol. 2021 Nov;148:103381. doi: 10.1016/j.jri.2021.103381. Epub 2021 Sep 9. J Reprod Immunol. 2021. PMID: 34563757 Review.
-
HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome.J Reprod Immunol. 2021 Jun;145:103291. doi: 10.1016/j.jri.2021.103291. Epub 2021 Feb 17. J Reprod Immunol. 2021. PMID: 33647576 Review.
Cited by
-
Considerations for Choosing Soluble Immune Markers to Determine Safety of Novel Vaginal Products.Front Reprod Health. 2022 May 17;4:899277. doi: 10.3389/frph.2022.899277. eCollection 2022. Front Reprod Health. 2022. PMID: 36303630 Free PMC article. Review.
-
Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives.PLoS One. 2023 Nov 10;18(11):e0294285. doi: 10.1371/journal.pone.0294285. eCollection 2023. PLoS One. 2023. PMID: 37948399 Free PMC article. Clinical Trial.
-
Ecology meets reproductive medicine in HIV prevention: the case for geography-informed approaches for bacterial vaginosis in Africa.Front Reprod Health. 2024 Nov 27;6:1431306. doi: 10.3389/frph.2024.1431306. eCollection 2024. Front Reprod Health. 2024. PMID: 39665036 Free PMC article. Review.
-
Starting to have sexual intercourse is associated with increases in cervicovaginal immune mediators in young women: a prospective study and meta-analysis.Elife. 2022 Oct 25;11:e78565. doi: 10.7554/eLife.78565. Elife. 2022. PMID: 36281966 Free PMC article.
-
Relationship between Bacterial Vaginosis and Sexually Transmitted Infections: Coincidence, Consequence or Co-Transmission?Microorganisms. 2023 Oct 1;11(10):2470. doi: 10.3390/microorganisms11102470. Microorganisms. 2023. PMID: 37894128 Free PMC article.
References
-
- Jespers V, van de Wijgert J, Cools P, Verhelst R, Verstraelen H, Delany-Moretlwe S, et al. . The Significance of Lactobacillus Crispatus and L. Vaginalis for Vaginal Health and the Negative Effect of Recent Sex: A Cross-Sectional Descriptive Study Across Groups of African Women. BMC Infect Dis (2015) 15(1):115. 10.1186/s12879-015-0825-z - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous